Natural Products and Bioactive Compounds to Help in the Fight against the COVID-19 Pandemic

A special issue of Foods (ISSN 2304-8158). This special issue belongs to the section "Nutraceuticals, Functional Foods, and Novel Foods".

Deadline for manuscript submissions: closed (30 June 2021) | Viewed by 36440

Special Issue Editors


E-Mail Website
Guest Editor
1. SPRINT Sport Physical Activity and Health Research & Innovation Center, Instituto Politécnico da Guarda, 6300-559 Guarda, Portugal
2. CICS/UBI, Universidade da Beira Interior, Covilhã, Portugal
Interests: bioactive compounds; phytochemicals; natural products as health promoters; chronic diseases
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
CICS-UBI—Health Sciences Research Centre, University of Beira Interior, Av. Infante D. Henrique, 6200-506 Covilhã, Portugal
Interests: pharmacokinetics; ADME; bioavailability; drug evaluation; drug delivery; systemic drug exposure
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The coronavirus disease-2019 (COVID-19), caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is an acute and contagious disease that is spread by human-to-human transmission via droplets or direct contact. It was first reported in Wuhan, China, spread worldwide rapidly, and was declared a global pandemic by the World Health Organization (WHO) in March 2020. Clinically, COVID-19 infection is characterized by pneumonia, fever, cough, and acute respiratory distress syndrome. Although many infections are asymptomatic, individuals with a compromised immune system and/or who have pre-existing respiratory, metabolic, or cardiac disorders are at an increased risk of suffering from serious illness or even death. Since the emergence of COVID-19, significant effort has been made to find preventive (vaccines) or therapeutic (drugs) agents to limit the spread of the infection and reduce the associated morbidity and mortality. It is well-known that one of the strategies to contain the pandemic is based on the strengthening the immune system. An optimal immune response depends on having an equilibrate and adequate nutritional status. Several bioactive compounds ingested daily in the diet may provide remarkable protection against contracting COVID-19. Compounds like vitamins A, C, D and E, phenolic compounds (e.g., curcumin, quercetin), carotenoids, omega-3 fatty acids, cinnamaldehyde, zinc, selenium, lactoferrin, dietary fiber, and probiotics have been described as having immune-boosting, antiviral, antioxidant, and anti-inflammatory properties. A poor nutritional status is associated with inflammation and oxidative stress which, in turn, can impact the immune system. Thus, the consumption of bioactive compounds in the right concentration may help to boost the immune system response, prevent virus spread, preclude disease progression to the severe stage, and further suppress the excessive inflammation response, providing both prophylactic and therapeutic support against COVID-19. Therefore, this Special Issue aims to gather the latest evidence on the importance of dietary components in reducing inflammation and oxidative stress, thereby strengthening the immune system during the COVID-19 pandemic.

Dr. Luís Manuel Lopes Rodrigues da Silva
Dr. Gilberto Alves
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Foods is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • COVID-19
  • bioactive compounds
  • antiviral properties

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (3 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Review

19 pages, 1179 KiB  
Review
Consumption of Phenolic-Rich Food and Dietary Supplements as a Key Tool in SARS-CoV-19 Infection
by José David Flores-Félix, Ana C. Gonçalves, Gilberto Alves and Luís R. Silva
Foods 2021, 10(9), 2084; https://doi.org/10.3390/foods10092084 - 3 Sep 2021
Cited by 9 | Viewed by 16421
Abstract
The first cases of COVID-19, which is caused by the SARS-CoV-2, were reported in December 2019. The vertiginous worldwide expansion of SARS-CoV-2 caused the collapse of health systems in several countries due to the high severity of the COVID-19. In addition to the [...] Read more.
The first cases of COVID-19, which is caused by the SARS-CoV-2, were reported in December 2019. The vertiginous worldwide expansion of SARS-CoV-2 caused the collapse of health systems in several countries due to the high severity of the COVID-19. In addition to the vaccines, the search for active compounds capable of preventing and/or fighting the infection has been the main direction of research. Since the beginning of this pandemic, some evidence has highlighted the importance of a phenolic-rich diet as a strategy to reduce the progression of this disease, including the severity of the symptoms. Some of these compounds (e.g., curcumin, gallic acid or quercetin) already showed capacity to limit the infection of viruses by inhibiting entry into the cell through its binding to protein Spike, regulating the expression of angiotensin-converting enzyme 2, disrupting the replication in cells by inhibition of viral proteases, and/or suppressing and modulating the host’s immune response. Therefore, this review intends to discuss the most recent findings on the potential of phenolics to prevent SARS-CoV-2. Full article
Show Figures

Graphical abstract

47 pages, 2835 KiB  
Review
Anti-Viral and Immunomodulatory Properties of Propolis: Chemical Diversity, Pharmacological Properties, Preclinical and Clinical Applications, and In Silico Potential against SARS-CoV-2
by Nermeen Yosri, Aida A. Abd El-Wahed, Reem Ghonaim, Omar M. Khattab, Aya Sabry, Mahmoud A. A. Ibrahim, Mahmoud F. Moustafa, Zhiming Guo, Xiaobo Zou, Ahmed F. M. Algethami, Saad H. D. Masry, Mohamed F. AlAjmi, Hanan S. Afifi, Shaden A. M. Khalifa and Hesham R. El-Seedi
Foods 2021, 10(8), 1776; https://doi.org/10.3390/foods10081776 - 31 Jul 2021
Cited by 54 | Viewed by 11942
Abstract
Propolis, a resin produced by honeybees, has long been used as a dietary supplement and folk remedy, and more recent preclinical investigations have demonstrated a large spectrum of potential therapeutic bioactivities, including antioxidant, antibacterial, anti-inflammatory, neuroprotective, immunomodulatory, anticancer, and antiviral properties. As an [...] Read more.
Propolis, a resin produced by honeybees, has long been used as a dietary supplement and folk remedy, and more recent preclinical investigations have demonstrated a large spectrum of potential therapeutic bioactivities, including antioxidant, antibacterial, anti-inflammatory, neuroprotective, immunomodulatory, anticancer, and antiviral properties. As an antiviral agent, propolis and various constituents have shown promising preclinical efficacy against adenoviruses, influenza viruses, respiratory tract viruses, herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2), human immunodeficiency virus (HIV), and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Over 300 chemical components have been identified in propolis, including terpenes, flavonoids, and phenolic acids, with the specific constituent profile varying widely according to geographic origin and regional flora. Propolis and its constituents have demonstrated potential efficacy against SARS-CoV-2 by modulating multiple pathogenic and antiviral pathways. Molecular docking studies have demonstrated high binding affinities of propolis derivatives to multiple SARS-CoV-2 proteins, including 3C-like protease (3CLpro), papain-like protease (PLpro), RNA-dependent RNA polymerase (RdRp), the receptor-binding domain (RBD) of the spike protein (S-protein), and helicase (NSP13), as well as to the viral target angiotensin-converting enzyme 2 (ACE2). Among these compounds, retusapurpurin A has shown high affinity to 3CLpro (ΔG = −9.4 kcal/mol), RdRp (−7.5), RBD (−7.2), NSP13 (−9.4), and ACE2 (−10.4) and potent inhibition of viral entry by forming hydrogen bonds with amino acid residues within viral and human target proteins. In addition, propolis-derived baccharin demonstrated even higher binding affinity towards PLpro (−8.2 kcal/mol). Measures of drug-likeness parameters, including metabolism, distribution, absorption, excretion, and toxicity (ADMET) characteristics, also support the potential of propolis as an effective agent to combat COVID-19. Full article
Show Figures

Figure 1

15 pages, 283 KiB  
Review
A Review of the Role of Micronutrients and Bioactive Compounds on Immune System Supporting to Fight against the COVID-19 Disease
by Montaña Cámara, María Cortes Sánchez-Mata, Virginia Fernández-Ruiz, Rosa María Cámara, Elena Cebadera and Laura Domínguez
Foods 2021, 10(5), 1088; https://doi.org/10.3390/foods10051088 - 14 May 2021
Cited by 33 | Viewed by 5694
Abstract
Micronutrients are critical for an adequate function of the immune system and play a vital role in promoting health and nutritional well-being. The present work is aimed at reviewing (1) the role of micronutrients in helping the immune system to fight against the [...] Read more.
Micronutrients are critical for an adequate function of the immune system and play a vital role in promoting health and nutritional well-being. The present work is aimed at reviewing (1) the role of micronutrients in helping the immune system to fight against the COVID-19 disease through the diet with food or food supplements and (2) the potential use of food health claims regarding immune function according to the European Food Safety Authority (EFSA) requirements. Till date, there are some health claims authorized by the European Commission that refer to the role of certain essential nutrients (vitamins B6, B9, B12, A, D, C, and Cu, Fe, Se) to contribute to the proper functioning of the immune system. Vitamins D, C, Zn, and Se, have been thoroughly studied as a strategy to improve the immune system to fight against COVID-19 disease. From all the micronutrients, Vitamin D is the one with more scientific evidence suggesting positive effects against COVID-19 disease as it is linked to a reduction of infection rates, as well as an improved outcomes in patients. To validate scientific evidence, different clinical trials are ongoing currently, with promising preliminary results although inconclusive yet. Full article
Back to TopTop